BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31697475)

  • 1. On-Demand Biodegradable Boron Nitride Nanoparticles for Treating Triple Negative Breast Cancer with Boron Neutron Capture Therapy.
    Li L; Li J; Shi Y; Du P; Zhang Z; Liu T; Zhang R; Liu Z
    ACS Nano; 2019 Dec; 13(12):13843-13852. PubMed ID: 31697475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
    Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.
    Lan KW; Huang WY; Chiu YL; Hsu FT; Chien YC; Hsiau YY; Wang TW; Keng PY
    Biomater Adv; 2023 Dec; 155():213699. PubMed ID: 37979440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
    Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.
    Chen J; Yang Q; Liu M; Lin M; Wang T; Zhang Z; Zhong X; Guo N; Lu Y; Xu J; Wang C; Han M; Wei Q
    Int J Nanomedicine; 2019; 14():8161-8177. PubMed ID: 31632025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
    Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
    Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Eradication by Boron Neutron Capture Therapy with
    Zhang Y; Kang HG; Xu HZ; Luo H; Suzuki M; Lan Q; Chen X; Komatsu N; Zhao L
    Adv Mater; 2023 Sep; 35(35):e2301479. PubMed ID: 37243974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Boron-10 nitride nanosheet for combinational boron neutron capture therapy and chemotherapy of tumor.
    Li L; Dai K; Li J; Shi Y; Zhang Z; Liu T; Jun Xie ; Ruiping Zhang ; Liu Z
    Biomaterials; 2021 Jan; 268():120587. PubMed ID: 33296793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography.
    Balcerzyk M; De-Miguel M; Guerrero C; Fernandez B
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932575
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyglycerol Functionalized
    Wang Y; Reina G; Kang HG; Chen X; Zou Y; Ishikawa Y; Suzuki M; Komatsu N
    Small; 2022 Sep; 18(37):e2204044. PubMed ID: 35983628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
    Achilli C; Grandi S; Ciana A; Guidetti GF; Malara A; Abbonante V; Cansolino L; Tomasi C; Balduini A; Fagnoni M; Merli D; Mustarelli P; Canobbio I; Balduini C; Minetti G
    Nanomedicine; 2014 Apr; 10(3):589-97. PubMed ID: 24161383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
    Kawasaki R; Hirano H; Yamana K; Oshige A; Nishimura K; Kono N; Sanada Y; Bando K; Tabata A; Yasukawa N; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Tarutani N; Katagiri K; Nagasaki T; Ikeda A
    Chembiochem; 2023 Aug; 24(15):e202300186. PubMed ID: 37069129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Nitroimidazole-Carbobane-Modified Phenylalanine Derivatives as Dual-Target Boron Carriers in Boron Neutron Capture Therapy.
    Li R; Zhang J; Guo J; Xu Y; Duan K; Zheng J; Wan H; Yuan Z; Chen H
    Mol Pharm; 2020 Jan; 17(1):202-211. PubMed ID: 31763850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
    Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
    J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.